Showing 1741-1750 of 2657 results for "".
- FDA Finds 'Substantive' Issues in Aldeyra’s NDA for Reproxalap for Dry Eye Diseasehttps://modernod.com/news/fda-finds-substantive-issues-in-aldeyras-reproxalap-drug-candidate-for-dry-eye-disease/2481895/Aldeyra Therapeutics was dealt a major setback this week as the FDA identified "substantive review issues" in the company’s new drug application for dry-eye disease treatment candidate reproxalap. In a US securities
- Resolving a Seeming Contradiction, Study Advances Understanding of Visual Recognition Memoryhttps://modernod.com/news/resolving-a-seeming-contradiction-study-advances-understanding-of-visual-recognition-memory/2481866/Researchers from The Picower Institute for Learning and Memory have published a study evaluating how our vision is so good at recognizing what’s familiar. The study, published in the Journa
- Trefoil Therapeutics Announces TTHX1114 Data Presentations at the ARVO 2023https://modernod.com/news/trefoil-therapeutics-announces-tthx1114-data-presentations-at-the-arvo-2023/2481536/Trefoil Therapeutics announced multiple presentations providing evidence for clinical and preclinical efficacy of the company’s investigational medicine TTHX1114 for improving visual outcomes and protection against corneal endothelial damage at the Annual Association for Research in Vision
- Allegro Ophthalmics Provides Updates on Dry AMD Pipeline Candidateshttps://modernod.com/news/allegro-ophthalmics-provides-updates-on-dry-amd-pipeline-candidates/2481403/Allegro Ophthalmics announced the presentation of data supporting dry AMD pipeline candidates, including risuteganib (Luminate), at the Bascom Palmer Eye Institute's 20th annual
- Harrow Launches Atropine.comhttps://modernod.com/news/harrow-launches-atropinecom/2481236/Harrow announced the launch of atropine.com, an ordering and marketing portal designed specifically for prescribers interested in compounded atropine formulations. All atropine.com, prescriptions will be dispensed through Harrow’s wholly owned
- PatientPoint Acquires Rendia to Accelerate Expansion into Ophthalmology Specialtyhttps://modernod.com/news/patientpoint-acquires-rendia-to-accelerate-expansion-into-ophthalmology-specialty/2481166/PatientPoint announced the acquisition of Rendia, a provider of point-of-care content for eye care providers sold on a subscription basis. Terms of the deal were not disclosed. With PatientPoint’s expansion into ophthalmology and optometry, PatientPoint’
- Heidelberg Engineering and AI Software Partners Present Workflow Solution for Ophthalmic Analytics at EURETINA and ESCRShttps://modernod.com/news/heidelberg-engineering-and-ai-software-partners-present-secure-workflow-solution-for-ophthalmic-analytics-at-euretina-and-escrs/2481050/Heidelberg Engineering is expanding its healthcare IT portfolio with the introduction of Heidelberg AppWay. This latest addition to the company’s ecosystem offers secure access to ophthalmic software analytics and AI-powered support systems, according to Heidelberg. It will be embedded into
- The Vision Council Releases Provider inSights Q1 2022 Reporthttps://modernod.com/news/the-vision-council-releases-provider-insights-q1-2022-report/2480877/The Vision Council has released the Provider inSights Q1 2022 Report. The publication of the report continues the roll-out of The Vision Council’s new
- C. Light Technologies Announces Activities and New Partnerships at ARVOhttps://modernod.com/news/c-light-technologies-announces-activities-and-new-partnerships-at-arvo/2480821/At this year’s Association for Research in Vision and Ophthalmology (ARVO), C. Light Technologies will meet with colleagues at booth #2424 to share engineering and software development updates from their new pipeline instrument,
- EssilorLuxottica and CooperCompanies Finalize Joint Venturehttps://modernod.com/news/essilorluxottica-and-coopercompanies-finalize-joint-venture/2480705/EssilorLuxottica and CooperCompanies have announced the finalization of their joint venture agreement for SightGlass Vision. This collaboration accelerates the commercialization of novel spectacle lens technologies to expand the myopia management category. SightGlass Vision’s Diffusion